Zhengping Zhuang

Zhengping Zhuang is an American physician-scientist and cancer researcher, widely recognized for his contributions to molecular pathology, cancer genetics, and translational oncology. He is Senior Investigator at the Neuro-Oncology Branch of the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). His work has advanced fundamental understanding of cancer biology and has contributed to multiple therapeutic innovations. Provided by Wikipedia
Showing 1 - 4 results of 4 for search 'Zhengping Zhuang', query time: 0.02s Refine Results
  1. 1
    A schema for sporadic and heritable disease pathogenesis integrating spatiotemporal distribution with the character of genetic variants

    A schema for sporadic and heritable disease pathogenesis integrating spatiotemporal distribution with the character of genetic variants by Hussam Alkaissi, Yasemin Cole, Tara T. Doucet-O’Hare, Jared S. Rosenblum, Zhengping Zhuang, Karel Pacak

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    HIF2A mediates lineage transition to aggressive phenotype of cancer-associated fibroblasts in lung cancer brain metastasis

    HIF2A mediates lineage transition to aggressive phenotype of cancer-associated fibroblasts in lung cancer brain metastasis by Muyuan You, Minjie Fu, Zhewei Shen, Yuan Feng, Licheng Zhang, Xianmin Zhu, Zhengping Zhuang, Ying Mao, Wei Hua

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Targeting the HLA-E–NKG2A axis in combination with MS-275 enhances NK cell-based immunotherapy against DMG

    Targeting the HLA-E–NKG2A axis in combination with MS-275 enhances NK cell-based immunotherapy against DMG by Yuxuan Deng, Jinqiu Liu, Zhuonan Pu, Yi Wang, Tian Li, Zhuang Jiang, Luyang Xie, Xiaoli Zhang, YingDan Chen, Mingxu Yang, Chao Du, Shuyu Hao, Nan Ji, Zhengping Zhuang, Jie Feng, Liwei Zhang

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    H1‐0 is a specific mediator of the repressive ETV6::RUNX1 transcriptional landscape in preleukemia and B cell acute lymphoblastic leukemia

    H1‐0 is a specific mediator of the repressive ETV6::RUNX1 transcriptional landscape in preleukemia and B cell acute lymphoblastic leukemia by Vera H. Jepsen, Andrea Hanel, Daniel Picard, Rigveda Bhave, Rebecca Hasselmann, Juha Mehtonen, Julian Schliehe‐Diecks, Carla‐Johanna Kath, Vithusan Suppiyar, Yash Prasad, Katerina Schaal, Jia‐Wey Tu, Nadine Rüchel, Ersen Kameri, Nan Qin, Herui Wang, Zhengping Zhuang, Rabea Wagener, Lena Blümel, Tobias Lautwein, Daniel Hein, David Koppstein, Gesine Kögler, Marc Remke, Sanil Bhatia, Merja Heinäniemi, Arndt Borkhardt, Ute Fischer

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: